Melatonin for diabetic nerve pain
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether melatonin can help relieve pain and discomfort from diabetic peripheral neuropathy (nerve damage caused by diabetes). If you have type 2 diabetes with nerve pain and are on stable diabetes medications, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have type 2 diabetes for at least 1 year.
- You have been diagnosed with diabetic peripheral neuropathy (nerve damage in your hands or feet).
- Your diabetes medications have been the same for at least the last month and will stay stable during the study.
- You do not have autoimmune diseases (like lupus or rheumatoid arthritis), thyroid disease, peripheral artery disease, or cancer.
- You are not taking any supplements or anti-inflammatory medicines (including antioxidants) now or in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether piracetam can help relieve nerve pain caused by diabetes (peripheral neuropathy). It's for people with type 2 diabetes who use insulin and have high blood sugar levels.
This trial tests whether a structured exercise program can help reduce pain, improve sleep, and lift mood in people with nerve pain from diabetes. If you have had diabetic nerve pain for at least 6 months and can do light exercise, this may be an option for you.
This trial tests a shortwave treatment to relieve pain and other nerve symptoms in people with diabetic peripheral neuropathy (nerve damage from diabetes). It is for adults who have not found enough relief from standard nerve medications.
This study tests whether vitamin D supplements can help reduce nerve pain and damage caused by type 2 diabetes. You may qualify if you have low vitamin D levels and have experienced nerve-related symptoms for at least 3 months.
This Phase 2 study tests whether melatonin can improve sleep and possibly outcomes related to diabetic retinopathy (damage to the retina from diabetes). It also checks whether it affects related symptoms while keeping people safe.
This study looks at how the central nervous system reacts in people with type 2 diabetes who have or don't have pain from nerve damage. It aims to better understand nerve sensitivity to help improve treatment.
Hear when a new Diabetic Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.